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Background. Since local tumor infiltration to the mesenteric-portal axis might represent a challenging assignment for curative
intended resectability during pancreatic surgery, appropriate techniques for venous reconstruction are essential. In this study, we
acknowledge the falciform ligament as a feasible and convenient substitute for mesenteric and portal vein reconstruction with
high reliability and patency for local advanced pancreatic tumor. Methods. A retrospective single-center analysis. Between June
2017 and January 2018, a total of eleven consecutive patients underwent pancreatic resections with venous reconstruction using
falciform ligament. Among them, venous resection was performed in nine cases by wedge and in two cases by full segment.
Patency rates and perioperative details were reviewed. Results. Mean clamping time of the mesenteric-portal blood flow was 34
min, while perioperative mortality rate was 0%. By means of Duplex ultrasonography, nine patients were shown to be patent on
the day of discharge, while two cases revealed an entire occlusion of the mesenteric-portal axis. Orthograde flow demonstrated a
mean value of 34 cm/s. All patent grafts on discharge revealed persistent patencywithin various follow-up assessments.Conclusion.
The falciform ligament appears to be a feasible and reliable autologous tissue for venous blood flow reconstruction with high
postoperative patency. Especially the possibility of customizing graft dimensions to the individual needs based on local findings
allows an optimal size matching of the conduit. The risk of stenosis and/or segmental occlusion may thus be further reduced.
1. Introduction
Pancreatic ductal adenocarcinoma is a common malignancy
of the gastrointestinal tract and incidences are unfortunately
evolving [1]. Despite continuous advancements in interdisci-
plinary treatment concepts, the majority of patients are still
diagnosed at advanced tumor stages and overall long-term
prognosis still remains limited [2]. As entire surgical tumor
removal remains the best chance for disease-free and long-
term survival, recent improvements in surgical expertise
have thus been focused on increasing surgical radicality
and margin-negative resections rates [3]. While hepatic
metastasis, peritoneal carcinomatosis, and/or invasion of
major vessels were traditionally considered as parameters for
nonresectability, progress in surgical techniques has, how-
ever, lead to a debate to redefine modern resection criteria
[4, 5]. Nowadays multivisceral resections (MVR) may be
considered as feasible and reliable procedures with decreasing
complication rates for selected patients [6]. According to this
continuous progress, resections of the superior mesenteric
vein (SMV), portal vein (PV), or coeliac axis are considered as
a safe and reliable technique when performed at high-volume
centers [7, 8]. Furthermore, recent studies have shown that
survival rates for patients undergoing pancreatectomy with
venous reconstruction were comparable to those undergoing
pancreatectomy exclusively [9, 10]. However, in case of
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vascular resection, suitable reconstruction techniques are
demanded in order to ensure unimpaired blood flow. When
primary direct closure of the venous vessel is not feasible
to restore continuity, complex segmental reconstruction,
requiring autologous tissue or synthetic materials, is essential
[8, 11, 12]. Previously we described bovine pericardium as
an innovative and feasible option for venous reconstruction
after pancreatic resection [13]. However, autologous materials
appear most suitable to maintain venous blood flow con-
tinuity and therefore the retrieval of the most appropriate
localization for withdrawal is still challenging [14, 15]. The
falciform ligament is a broad and thin fold of the peritoneum,
attaching the liver to the anterior parietal and diaphragmatic
peritoneum, also separating the left and right lobe of the liver.
Meaning “sickle-shaped”, from Latin, it is a remnant of the
embryonic ventral mesentery with its base being directed
downward and backward and its apex upward and backward
[16, 17]. Both sides are covered by layers of mesothelial cells
and can become canalized in cases of portal hypertension
[18, 19]. We herewith report on our initial experience with
the falciform ligament as an autologous graft for portal
and superior mesenteric vein reconstruction in extended
pancreatic resections and provide a surgical guide based on
our perioperative outcomes.
2. Methods
2.1. Patients’ Inclusion Criteria and Data Collection. This was
a retrospective single-center analysis conducted in a tertiary
referral center for pancreatic surgery. Standard preopera-
tive clinical diagnostics included a physical examination
and routine laboratory testing. Computed tomography (CT)
and/or magnet resonance imaging (MRI) were routinely
used as radiological diagnostic tools to analyze tumor diag-
nosis as well as the stage of the disease. Indications for
pancreatic resections were endorsed in an interdisciplinary
consensus meeting. All included operations were performed
by experienced pancreatic surgeons at the study site and
all oncological procedures, as well as venous resections,
were performed as open surgical procedures according
to international standards [20]. There were no minimal-
invasive pancreatectomies within the study group. Accord-
ingly, between June 2017 and January 2018, we identified
and reviewed an overall of eleven patients who had under-
gone en bloc tumor resection with simultaneous venous
vascular resection and reconstruction of the venous blood
continuity using a falciform ligament graft within our study
period. Written informed consent was obtained from all
patients.
The following data were collected for each patient:
demographics (age, gender); underlying diagnosis; surgical
procedure; neoadjuvant chemotherapy; results of the final
histopathological examination, including TNM classifica-
tion; operative details such as operation time, clamping time,
and intraoperative transfusion; associated vein resection and
reconstruction graft within surgical procedure; details of
the perioperative course such as postoperative morbidity in
terms of postoperative pancreatic fistula (POPF), postpan-
createctomy haemorrhage (PPH), and abdominal collection
which were all classified according to International Study
Group of Pancreatic Fistula (ISGPF) definitions [21, 22];
length of hospital stay (LOS) was calculated from the day of
surgery until the day of discharge; patency of vein and results
of orthograde flow measurement during Duplex ultrasonog-
raphy.
2.2. Preconditioning, Technique, and Surgical Guide. When
preoperative CT or MRI showed tumor involvement of
the celiac axis and/or the common hepatic artery (CHA)
but no affiliation to the superior mesenteric artery (SMA)
or the gastroduodenal artery (GDA), patients were fur-
ther evaluated for distal celiacopancreatectomy. If exam-
inations revealed eligible conditions for resection, preop-
erative embolization of the celiac axis and the CHA was
performed. Hereby the arterial blood supply to the liver
and stomach was enhanced through collateral pathways
from the SMA over the pancreaticoduodenal arcades to the
GDA, the proper hepatic artery (PHA), the gastroepiploic
artery, and the right gastric artery as previously described
[23].
At the beginning of the operation, peritoneal metastases
were initially excluded by complete exploration of the abdom-
inal cavity. Access to the omental bursa was established by
dissection of the gastrocolic ligament. After retraction of the
stomach and inspection of the pancreas, local resectability of
the lesion and the extent of the resection were determined
based on local findings such as vascular and/or another
organ infiltration. In cases of underlying malignant disease, a
standard lymphadenectomywas performed.Dissection of the
pancreas was done by electrocautery, or in cases of pancreatic
left resections with a stapling device.
In the event of underlying venous infiltration, all veins
draining into the impaired segment were clamped and en
bloc resection including tumor and vein was conducted.
In order to avoid edema in the bowel, cross-clamp time
was kept to a minimum. Grafts of the falciform ligament
were tailored to the individual needs based on local find-
ings. Therefore, patches from the falciform ligament were
retrieved by scissor and kept in saline. In order to shape
cylindrical interposition grafts, patches were rolled over a
tube and sutured. Preparation of the interposition graft, as
well as patch insertion and anastomoses, were all completed
by 6.0 Prolene sutures (Ethicon, Norderstedt, Germany).
Cases which required only partial resection of the venous
circumference were provided by patch graft (Figure 1),
whereas interposition grafts were used to replace segments
affected with tumor infiltration of more than half the cir-
cumference of the vessel (Figure 2). A growth factor was
applied in all anastomosis in order to allow expansion of
the suture line as previously described [24]. In case of a
pancreatoenteral anastomosis, either a pancreatojejunostomy
or a pancreatogastrostomy was performed. Distal closure of
the pancreas remnant by stapler was performed using linear
stapling devices armed with a 60-mm cartridge (EndoGIA,
Auto- Suture, Covidien) reinforced by a bioabsorbable mesh
(SEAMGUARD, W.L. Gore, Flagstaff, AZ). Every patient
received at least one intra-abdominal drain (Degania Silicone
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Figure 1: Intraoperative perspective after pylorus-preserving pan-
creaticoduodenectomy (PPPD) with partial resection of the portal
vein and successful reconstruction by patch graft.
Figure 2: Intraoperative perspective after distal pancreatectomy
with en bloc resection of the celiac trunk as well as portal vein
segment and successful reconstruction by interposition graft.
Europe GmbH, Regensburg, Germany) to measure postop-
erative amylase levels and drain output in the postoperative
course.
2.3. Standard Postoperative Care. Postoperative care was
standardized. All patients were monitored for at least one
day at a specialized surgical intensive care unit. Anticoagu-
lant therapy after venous reconstruction was performed by
continuous administration of unfractionated heparin (UFH)
to achieve a PTT of 40-50 seconds for 5 days. Laboratory
testing for coagulation variables was performed every 8 hours
according to standard ICU care. Afterward, prevention of
venous thromboembolism was achieved by subcutaneous
application of low molecular weight heparin (LMWH) based
on patient’s requirement throughout the length of hospital
stay. Specific procedure related anticoagulation therapy was
discontinued after discharge and only continued if required
Figure 3: Duplex ultrasonography examination to verify unim-
paired portal blood flow in the postoperative course.
by additional comorbidities or the underlying diagnose of the
individual patient. Portal and superior mesenteric vein blood
flow was evaluated by Duplex ultrasonography intraopera-
tive, immediately postoperative as well as on the first and
second postoperative day. Final Duplex ultrasonography was
performed prior to discharge (Figure 3). If normal hilar portal
blood flow along normal liver function was verified, graft
patency was assumed sufficient. Contrast-enhanced abdomi-
nal computed tomography scanning was not performed reg-
ularly but rather on the clinical requirement. Amylase levels
were monitored in the serum and in the intraoperatively
placed abdominal drains on the second postoperative day.
In the absence of signs of a pancreatic fistula, oral food
intake was started depending on the clinical presentation and
tolerance. The concept of enhanced recovery after surgery
(ERAS) has not been applied within the study period.
Adjuvant chemotherapy followed depending on the TNM
category and clinical situation. All comprehensive procedures
were reviewed in an interdisciplinary consensus meeting and
patients were seen routinely for follow-up examinations in
the outpatient clinic.
3. Results
3.1. Baseline Characteristics. Between June 2017 and Jan-
uary 2018, a total of eleven consecutive patients underwent
pancreatic resections with venous reconstruction by the
falciform ligament for extended pancreatic tumor disease at
our institution; among them five patients underwent pylorus-
preserving pancreaticoduodenectomy (PPPD), two patients
received a pylorus preservation total pancreatectomy, two
patients received a distal pancreatectomy with splenectomy,
and two patients required an Appleby procedure in order
to achieve radical tumor removal. There were six males and
five females with a mean age of 63 years (43–82) in this
group. Three patients received a neoadjuvant chemotherapy,
exclusively by FOLFIRINOX, according to an endorsement
by an interdisciplinary consensus meeting. Venous resec-
tion was performed in nine patients by wedge and in two
patients by full segment resection. All venous reconstructions
were performed utilizing portions of the falciform ligament.
Histological examination showed ductal adenocarcinomas
in ten patients, while one patient suffered from an invasive
intraductal papillary mucinous carcinoma (IPMC) of the
pancreas. In four cases complete resection of tumor tissue
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was achieved, while in seven cases residual tumor was
present microscopically at retroperitoneal resection margins
(Table 1).
3.2. Perioperative and Postoperative Data. Themean duration
of the surgical procedure was 361 min, while mean clamping
time of the mesenteric-portal blood flow was 34 min. In
seven patients the portal vein was solely infiltrated by tumor,
whereas in four cases tumor involvement of the confluence
was determined. Nine cases were provided by patch graft,
while two patients required an interposition graft due to a
segmental tumor infiltration of more than half the circum-
ference of the underlying venous vessel. In six patients a
transfusion of red blood cells (RBC) and fresh frozen plasma
(FFP) was necessary during the intraoperative course. Mean
ICU length of stay and overall hospital stay was 4 (1-12)
and 23 (12-59) days, respectively. The perioperative mortality
rate was 0%. Two patients developed POPF grade B, while
two patients sustained post pancreatectomy haemorrhage. In
one case, a bleeding from the anastomosis of the interposi-
tion graft occurred and surgical revision was required. The
other case demonstrated a bleeding from the gastroduodenal
artery, although no pancreatic fistula was observed. Coiling
of the stump of the GDA stopped PPH and no surgical
intervention was necessary. Both cases of POPF grade B were
managed by percutaneous drainage and fistula resolved in the
course without further intervention. In one patient, a CT scan
revealed an abdominal collection, which was approached
by CT guided percutaneous drainage. By means of Duplex
ultrasonography, nine patients were shown to be patent on the
day of discharge, while two cases revealed an entire occlusion
of the mesenteric-portal axis. Both patients presented ascites
in the postoperative course and required diuretics. Reopening
by interventional approach was unsuccessfully attempted in
one patient. Both patients received anticoagulant therapy
and could be discharged uneventfully. Orthograde flow
demonstrated a mean value of 34 cm/s for patent grafts.
All patent grafts on discharge revealed persistent patency
within various assessments in our oncological outpatient
clinic or direct communication with the general practitioner
(Table 2). After discharge, eight patients were included in
the study protocol of the Hyperthermia European Adjuvant
Trial (HEAT; ClinicalTrials.gov Identifier: NCT01077427)
for further treatment, based on the recommendations of
the interdisciplinary consensus meeting. Two patients sus-
tained FOLFIRINOX for their adjuvant treatment, while
to one patient gemcitabine/nab-paclitaxel was administered
(Table 2).
4. Discussion
Clinical outcome after pancreatic surgery has improved
considerably over the last decades with a consistent reduc-
tion of postoperative morbidity and mortality [25]. While
previous studies indicated no significant differences in terms
of postoperative morbidity and long-term survival after
pancreatectomywithmesenteric-portal vein resection, recent
studies demonstrated beneficial outcomes and increased
resectability rates for patients with underlying pancreatic
malignancies [5, 9, 26]. Since local tumor infiltration to the
venous blood flow might represent a challenging assignment
for curative intended resectability, appropriate techniques
for venous reconstruction are essential [27, 28]. In this
study, we acknowledge the falciform ligament as a feasible
and convenient substitute for mesenteric and portal vein
reconstruction with high patency and reliability in extended
pancreatic tumor resections.
After venous resection has been performed, rearrange-
ment of the mesenteric-portal axis is essential to ensure
unimpaired blood flow continuity. Even though the primary
direct closure of the venous vessel is frequently feasible,
pancreatic surgeons partially encounter complex situations
requiring additional tissue for reconstruction [14, 29, 30].
Various autologous grafts have been described in the liter-
ature, including the great saphenous vein, internal jugular
vein, femoral vein, left renal vein, or gonadal veins [11, 12, 31–
33]. Harvesting of these grafts may, however, be accompanied
by relevant morbidity due to the impermanent into another
anatomic region [12, 34, 35]. Postoperative edema, increased
operative time, increased risk of bleeding or size mismatches
resulting in deficient portal inflow with an increased risk
of turbulence that might promote clotting of the graft are
frequently reported [8]. In addition, synthetic grafts com-
posed of polytetrafluoroethylene (PTFE) or polyethylene
terephthalate (Dacron) contain a seriously substandard risk
of thrombosis and infection and an elongated anticoagulation
therapy postoperative is demanded [36]. Consequently, also
synthetic grafts are not commonly recommended as grafts for
mesenteric and portal vein reconstruction and therefore the
most suitable tissue still remains to be identified [28, 37].
Previously we described bovine pericardium as a safe and
feasible material for mesenteric and portal vein reconstruc-
tion during pancreatic surgery and indicated good patency
and easy handling [13]. Although the introduced procedure
is still frequently implemented in our tertiary referral center
for pancreatic surgery, we targeted an even more autologous
and cost-effective solution.
The falciform ligament, a remnant of the embryonic
ventral mesentery, is a broad and thin fold of the peritoneum
that is covered with epithelial layers on both sides featur-
ing several advantages. Within our observation period, we
discovered good graft patency, which is comparable with
results of other studies using different autologous tissue or
interposition grafts compounded by PTFE [32, 37]. How-
ever, retrieval, as well as implementation, is much easier
and dimensions can be customized to the individual needs
based on intraoperative findings. Furthermore, due to its
autologous nature, the risk of infection and the necessity for
long-term anticoagulation therapy postoperative is limited.
In addition, cost-effective availability results in verifiable
benefits in favor of the autologous falciform ligament. Sur-
prisingly, our results are in contrast to a comparable study
also targeting the falciform ligament as a graft for portal
and mesenteric vein reconstruction. Zhiying et al. reported
good graft patency until two weeks postoperatively, while
an increased occlusion rate up two months postoperatively


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































findings are very difficult to distinguish and due to the small
number of cases within both series, further studies need to
trace long-term patency and overall outcome. Nevertheless,
information regarding the chosen suture material, as well as
placement of a growth factor, has not been depicted within
their manuscript and could therefore possibly be accountable
for the documented stenosis and occlusion in the follow-
up. Although there is a significant heterogeneity regarding
anticoagulation after venous reconstruction with pancreatic
resection and currently no agreed approach available [36],
continuous administration of unfractionated heparin (UFH)
to achieve a PTT of 40-50 seconds for 5 days was conducted
in our series by contrast. However, a significant impact on
occlusion rates in the course remains debatable.
The most frequent complication in our series was the
occurrence of a pancreatic fistula, which can be seen as
being related to the pancreatic resection itself. However,
two patients were consequently affected by PPH demanding
further intervention. In one case bleeding occurred from the
stump of the gastroduodenal artery, which was controlled
by an angiographic procedure, while the other patient was
impaired from a direct bleeding from the venous interposi-
tion graft due to an occult arrosion of the suture material.
According to other series, PPH occurred frequently and
appears to be independent of the chosen tissue for venous
reconstruction [39].
Microscopic resection margin involvement (R1 resection)
was present in 7 patients, of which all involved the retroperi-
toneal margins. However, superior mesenteric-portal vein
resections including tangential resection with a patch or
segmental resectionwith interposition graft revealedmargin-
free resections at this point in all eleven cases. Accordingly,
the falciform ligament appears to be a safe and feasible
substitute to achieve venous R0 resections when the tumor
cannot be separated from the venous axis.
The present study is, of course, limited by common biases
that are mainly due to the retrospective character of this
analysis and the heterogonous time specification concerning
long-term longevity.Therefore, further studies with increased
numbers of cases need to determine observations.
In conclusion, pancreatectomy with resection of the
mesenteric-portal axis due to tumor infiltration provides
the chance for complete tumor resection. In our series,
the falciform ligament appears to be a feasible and reli-
able autologous tissue for venous blood flow reconstruction
with high postoperative patency and low risk of infection.
Due to the possibility of customizing graft dimensions to
the individual needs based on local findings, optimal size
matching of the conduit is feasible and thus the formation of
stenosis and segmental occlusionmay be less likely. Although
rates of patency in our patients are promising, conclusions
on longevity still need to be evaluated in further enlarged
observations.
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